118 related articles for article (PubMed ID: 32307656)
21. Life Expectancy and Treatment Patterns in Elderly Patients With Low-Risk Papillary Thyroid Cancer: A Population-Based Analysis.
Lohia S; Gupta P; Curry M; Morris LGT; Roman BR
Endocr Pract; 2021 Mar; 27(3):228-235. PubMed ID: 33779556
[TBL] [Abstract][Full Text] [Related]
22. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
[TBL] [Abstract][Full Text] [Related]
23. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
[TBL] [Abstract][Full Text] [Related]
24. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
[TBL] [Abstract][Full Text] [Related]
25. Long-term oncologic outcome of robotic versus open total thyroidectomy in PTC: a case-matched retrospective study.
Lee SG; Lee J; Kim MJ; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
Surg Endosc; 2016 Aug; 30(8):3474-9. PubMed ID: 26514137
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
27. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
[TBL] [Abstract][Full Text] [Related]
28. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
[No Abstract] [Full Text] [Related]
29. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
30. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
31. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
Kwon H; Moon BI
World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
[TBL] [Abstract][Full Text] [Related]
33. Oncologic outcomes of robotic thyroidectomy: 5-year experience with propensity score matching.
Tae K; Song CM; Ji YB; Sung ES; Jeong JH; Kim DS
Surg Endosc; 2016 Nov; 30(11):4785-4792. PubMed ID: 26895921
[TBL] [Abstract][Full Text] [Related]
34. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
35. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
[TBL] [Abstract][Full Text] [Related]
37. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
Sun J; Huang Z; Hu Z; Sun R
J Transl Med; 2017 May; 15(1):116. PubMed ID: 28558725
[TBL] [Abstract][Full Text] [Related]
38. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
Song E; Han M; Oh HS; Kim WW; Jeon MJ; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Sung TY; Kim WG
Thyroid; 2019 Jan; 29(1):64-70. PubMed ID: 30375260
[TBL] [Abstract][Full Text] [Related]
39. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.
Lin HW; Bhattacharyya N
Laryngoscope; 2010 Apr; 120(4):712-6. PubMed ID: 20205241
[TBL] [Abstract][Full Text] [Related]
40. Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer.
Al-Qurayshi Z; Bu Ali D; Srivastav S; Kandil E
Oncology; 2017; 93(2):122-126. PubMed ID: 28609768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
